Metabolic dysfunction-associated steatotic liver disease (MASLD) can be a possible predictive factor of incident CKD: NAGALA cohort study
This study establishes MASLD as a significant risk factor for CKD onset. Effective identification and management of MASLD cases are essential to mitigate the incidence of CKD.
Authors
- Akihiro Obora
- Kimiko Sakai (ORCID: https://orcid.org/0000-0002-8901-2723)
- Takuro Okamura (ORCID: https://orcid.org/0000-0001-7269-1697)
- Yuriko Ono
- Hiroshi Okada (ORCID: https://orcid.org/0000-0002-1707-970X)
- Takao Kojima (ORCID: https://orcid.org/0000-0001-9689-2098)
- Michiaki Fukui (ORCID: https://orcid.org/0000-0003-0903-1797)
- Masahide Hamaguchi (ORCID: https://orcid.org/0000-0002-8651-4445)
Institutions
- Asahi University (JP)
- Kyoto Prefectural University of Medicine (JP)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1371/journal.pone.0334720
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00